HOME >> MEDICINE >> NEWS
VELCADE (Bortezomib) receives European marketing authorisation

ghted that marketing authorisation for VELCADE has been granted, as it is the first major advance for patients with multiple myeloma in more than a decade, and marks the company's commitment to Oncology." said Ken Watters, European Medical Director, Ortho Biotech.

"The approval of VELCADE today brings renewed hope to thousands of European multiple myeloma patients and their families" said Eric Low, Executive Director, International Myeloma Foundation (UK). "The multiple myeloma advocacy community has campaigned tirelessly over the years for cutting edge treatments such as VELCADE to be made available to patients, this is a very proud day", he continued.

The findings of a pre-specified interim analysis from an ongoing phase III trial which compared VELCADE to dexamethasone in refractory multiple myeloma patients found a statistically significant improvement in time to disease progression the primary endpoint of the trial in patients receiving VELCADE compared to patients receiving high-dose dexamethasone. Patients in the control arm of the trial were given the opportunity to switch to VELCADE as soon as possible based on an interim analysis that found a statistically significant improvement in TTP in patients receiving VELCADE compared to patients receiving dexamethasone.

VELCADE has a generally predictable, manageable safety profile (with appropriate monitoring and if necessary, dose modification). VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol. There are approximately 50 ongoing clinical trials (in Europe and the US) investigating the potential of VELCADE in all stages of multiple myeloma and other cancers.

A single licence has been granted to market VELCADE in the 15 member states of the EU, plus Norway and Iceland. In addition it will be available in the 10 accession countries.

VELCADE is being co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Ph
'"/>

Contact: Eva Reynolds
eva_reynolds@uk.bm.com
44-20-7831-6262
Burson-Marsteller
28-Apr-2004


Page: 1 2 3

Related medicine news :

1. VELCADE(TM) data confirms long-term survival
2. UIC professor receives international humanitarian award
3. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
4. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
5. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
8. American Academy of Neurology program receives Grassroots Award
9. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
10. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
11. Pfizers antifungal medicine VFEND receives FDA approval

Post Your Comments:
(Date:3/27/2015)... London, UK (PRWEB) March 27, 2015 ... that it has appointed Sean Fitzgerald, a former technology ... Chief Operating Officer and Interim Chief Financial Officer. , ... leading education technology innovator, EverFi, backed by Amazon founder ... Twitter founder Evan Williams. Prior to EverFi, he was ...
(Date:3/27/2015)... Bellevue, WA (PRWEB) March 27, 2015 ... it can be hard to know where to begin. ... an experienced Seattle trucking accident attorney, offers accident victims ... financial, and legal assistance to ensure their personal injury ... eBook begins by describing the first actions that should ...
(Date:3/27/2015)... 27, 2015 Approximately 300 advocates ... Kids Coalition Lobby Day to lobby for physical ... Program (SHIP). Everlast Climbing was especially interested ... SF343/HF498 which would strengthen physical education programs by ... and other measures to strengthen physical education in ...
(Date:3/27/2015)... 2015 Canadian Cannabis Clinics ( ... and utilization of medical cannabis as a treatment ... doctors and clinics dedicated to providing access to ... gateway for patients searching for medical marijuana treatment ... launched their sub domain for Canada. , ...
(Date:3/27/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... Peace is through the Laws of Peace written in the ... The article titled, “Yahweh’s Way-The Great Difference” focuses on the ... from the original biblical instructions has caused mass chaos worldwide. ... created in the world is based on man-made laws that ...
Breaking Medicine News(10 mins):Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Canadian Cannabis Clinics (CCC) to Join the Canada.MarijuanaDoctors.com Network 2Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2
(Date:3/26/2015)... 2015 When they began experiencing significant ... vendor their system would no longer be supported, ... a better structured solution to support their radiology ... to its interface capabilities and its 2014 EHR ... to the hospital,s radiology department. Avreo,s experienced team ...
(Date:3/26/2015)...  CCS Medical ("CCS"), one of the nation,s ... with chronic conditions, has named Rodney Carson ... March 23.  Mr. Carson joins CCS from MDLIVE, ... President of Operations. Prior to ... President of Operations at NationsHealth, (n/k/a Convey Health ...
(Date:3/26/2015)... , March 26, 2015 Zimmer Holdings, Inc. ... ® Advanced Bearing Technology with Vitamin E ... paper published earlier this month reported that, at 96 ... Advanced Bearing Technology featuring Vitamin E grafted highly ... significant wear rate reduction of 95 percent, with no ...
Breaking Medicine Technology:Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
Cached News: